Diagnosis of myeloma in complex clinical scenarios

During COMy 2020, Shaji Kumar, Mayo Clinic, Rochester, US, spoke to the Multiple Myeloma (MM) Hub about the diagnosis of MM in complex clinical scenarios.

One of the major challenges surrounding the diagnosis of MM is deciphering patients who require treatment versus those presenting with early-stage disease, such as monoclonal gammopathy of undetermined significance (MGUS) or smoldering MM. Here, Shaji Kumar discusses the evolution of diagnostic criteria to include features other than those solely identifying active MM. Although currently a 'work in progress', the revised criteria promise to improve patient prognosis.